Cargando…
Unprotected versus protected high-risk percutaneous coronary intervention with the Impella 2.5 in patients with multivessel disease and severely reduced left ventricular function
Selecting a revascularization strategy in patients with multivessel disease (MVD) and severely reduced left ventricular ejection fraction (LVEF) remains a challenge. PCI with Impella 2.5 may facilitate high-risk PCI, however long-term results comparing unprotected versus protected PCI are currently...
Autores principales: | Becher, Tobias, Eder, Frederik, Baumann, Stefan, Loßnitzer, Dirk, Pollmann, Berit, Behnes, Michael, Borggrefe, Martin, Akin, Ibrahim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6221604/ https://www.ncbi.nlm.nih.gov/pubmed/30412063 http://dx.doi.org/10.1097/MD.0000000000012665 |
Ejemplares similares
-
Left Ventricular Support for Unprotected Left Main Coronary Artery Interventions (The Dayton Heart and Vascular Impella Registry)
por: Jabbar, Ali Abdul, et al.
Publicado: (2022) -
Nonemergent Percutaneous Coronary Intervention on an Unprotected Left Main Coronary Artery Supported with Impella® Heart Pump in Patients Ineligible for Surgical Revascularization
por: Meraj, Perwaiz M., et al.
Publicado: (2019) -
Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis
por: Hori, Takayuki, et al.
Publicado: (2022) -
Single vascular access for concomitant percutaneous coronary intervention and left ventricular assistance with Impella
por: Lyra, Flávio, et al.
Publicado: (2021) -
Optimal duration for dual antiplatelet therapy with COMBO dual therapy stent
por: Huseynov, Aydin, et al.
Publicado: (2019)